Vimian Group
30.20 SEK
-2.11 %
Less than 1K followers
VIMIAN
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vimian Group
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 1,776.8 | 3,142.4 | 3,693.5 | 4,298.8 | 4,591.2 |
| growth-% | 76.9 % | 17.5 % | 16.4 % | 6.8 % | |
| EBITDA | 392.4 | 743.9 | 816.1 | 950.8 | 1,132.1 |
| EBIT | 221.4 | 439.7 | 459.5 | 564.3 | 721.6 |
| Profit before taxes | 130.8 | 10.3 | 216.6 | 331.5 | 495.8 |
| Net income | 79.5 | -80.4 | 116.7 | 221.4 | 348.9 |
| EPS | 0.21 | -0.22 | 0.22 | 0.46 | 0.65 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 0.0 % | -0.0 % | 0.0 % | 0.0 % | 0.0 % |
Profitability and return on capital
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| EBITDA-% | 22.1 % | 23.7 % | 22.1 % | 22.1 % | 24.7 % |
| EBIT-% | 12.5 % | 14.0 % | 12.4 % | 13.1 % | 15.7 % |
| ROE | 2.2 % | -1.5 % | 2.0 % | 2.7 % | 4.6 % |
| ROI | 1.2 % | -0.8 % | 1.1 % | 1.7 % | 2.9 % |